Aurinia Pharmaceuticals Inc.

Ownership Transactions Reported by 26 Insiders

	Insiders	Shares	%	Avg Price	Total $
Buys	1	+4.1M	84.1%	$9.05	+$37.1M
Sells	7	-776K	15.9%	$8.04	-$6.24M
Net	-6	+3.32M	68.2%		+$30.9M

Name	Relationship	Holdings Value	Past Year Net Change	Change %	Report Date
Kevin Tang	Director	$132M	+$37.1M	+39%	Aug 1, 2025
Peter Greenleaf	Chief Executive Officer, Director	$14.2M	-$2.87M	-16.8%	Feb 28, 2025
Matthew Maxwell Donley	Chief Operating Officer	$5.39M	-$994K	-15.6%	Feb 28, 2025
Joseph M. Miller	Chief Financial Officer	$4.57M	-$940K	-17%	Feb 28, 2025
Stephen P. Robertson	EVP, General Counsel	$4.03M	-$975K	-19.5%	Feb 28, 2025
Michael Robert Martin	Chief Business Officer	$2.92M			Mar 2, 2023
Scott Habig	Chief Commercial Officer	$2.42M			Aug 6, 2024
Volker Knappertz	EVP, Research and Development	$1.95M			Feb 27, 2024
Greg Keenan	Chief Medical Officer	$1.4M	-$376K	-21.2%	Aug 1, 2025
Neil Solomons	Chief Medical Officer	$1.02M			Mar 2, 2022
George M. Milne Jr	Director	$887K			May 18, 2023
Robert Bindert Huizinga	EVP of Research	$781K			Mar 2, 2022
David R.W. Jayne	Director	$476K			Nov 21, 2024
Jeffrey A. Bailey	Director	$215K	-$38.4K	-15.2%	May 16, 2025
Jill Leversage	Director	$211K			Nov 21, 2024
Karen L. Smith	Director	$209K	-$44.2K	-17.4%	Nov 21, 2024
Craig Johnson	Director	$174K			May 16, 2025
Daniel Billen	Director	$162K			May 21, 2024
Massimilano Colao	Chief Commercial Officer	$152K			Mar 2, 2022
Joseph P. Hagan	Director	$135K			May 18, 2023
R. Hector MacKay-Dunn	Former Director	$107K			Sep 9, 2024
Brinda Balakrishnan	Director	$101K			May 21, 2024
Tina Susan Nova	Director				May 16, 2025
Kathleen Goetz	Director				May 16, 2025
Robert T. Foster	Director				Sep 21, 2023
Timothy P. Walbert	Director				May 18, 2022

Insider	Symbol	Class	Transaction	%	Value $	* Price $	Shares	Shares Owned	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.